AARA News
Dr. John R. P. Tesser Awarded Master Designation by ACR
Felicitations to our own Dr. John. R.P. Tesser, MD, FACP, FACR, MACR, for receiving the Master Designation from the American College of Rheumatology (ACR). Recognition as a Master of the American College of Rheumatology is one of the highest honors the College bestows. The designation of Master is conferred on ACR members who have made outstanding contributions to the ACR and the field of rheumatology through scholarly achievement and/or service to their patients, students, and profession.
We congratulate Dr. Tesser on this significant honor and thank him for his valuable contributions to the field of rheumatology at large.
Lindsay DeWolfe Wins 2024 Community Choice Excellence in Healthcare Award
Lindsay DeWolfe, DNP, FNP-C, of Arizona Arthritis & Rheumatology Associates, has been honored with the 2024 Community Choice Award for Outstanding Healthcare Professional. Specializing in Ehlers-Danlos syndrome (EDS), Lindsay has revolutionized patient care with a comprehensive approach that includes personalized treatment plans and unwavering support. Her impactful work has earned her the Healthcare Professional of the Year award, as voted by the EDS & HSD community.
Lindsay DeWolfe, DNP, FNP-C, is a dedicated practitioner at Arizona Arthritis & Rheumatology Associates, specializing in diagnosing and directing care for EDS patients. She has created a comprehensive roadmap to facilitate the healing journey, tirelessly providing resources and information to support EDS patients, ensuring a safe space free from the gaslighting often encountered. Her impactful work has earned her the Healthcare Professional of the Year award, as voted by the EDS & HSD community.
“Lindsay has been integral to the outreach and ability to help so many get diagnosed in the state of Arizona and even outside of it. Since she has joined AARA Rheum practice she has widened the scope of our ability to serve the under-served in this community. She created the famous “EDS Roadmap” to help facilitate and direct care for our zebras in the valley. Without her, we wouldn’t have reached so many more souls in need of this diagnosis and care. She’s one in a million!!!”
Congratulations, Lindsay, on this well-deserved recognition!
Weather changes fail to impact risks for osteoarthritis pain, rheumatoid arthritis
Weather changes are not risk factors for rheumatoid arthritis or knee, hip or low back pain, but do appear to influence gout flares, according to a meta-analysis published in Seminars in Arthritis and Rheumatism.
“The weather is frequently blamed for changes in musculoskeletal health,” Manuela L. Ferreira, PhD, of the University of Sydney, told Healio. “However, this belief is not consistently supported by research.”
Drug costs and nocebo risks: Navigating the Humira ‘biosimilar boom’ 1 year later
The first Humira biosimilar hit the U.S. market a little over a year ago. Since then, a total of nine biosimilars for Humira (adalimumab, AbbVie) have launched, including two with interchangeable status. However, despite promises of greater competition and reduced prices, it remains to be seen, now a full year from the launch of Amjevita (adalimumab-atto, Amgen) in January 2023, what impact these drugs will — or can — have on the U.S. pharmaceutical market and drug pricing system.
